Mutations in the BRCA1 and BRCA2 genes confer a greatly increased risk of b
reast cancer, ovarian cancer, and other malignant diseases. This paper offe
rs recommendations about who should be screened for BRCA mutations, and ins
ights into the ramifications of BRCA testing.